The nonprofit, Baltimore-based Lieber Institute for Brain Development, an affiliate of Johns Hopkins University School of Medicine, is partnering with Astellas…

The Japanese Global Health Innovative Technology Fund said it will invest nearly $15 million to advance new drugs for neglected tropical diseases as well as…

AstraZeneca's biologics arm MedImmune has tapped the University of California, San Francisco for a three-year drug discovery and development…

With drug-resistant tuberculosis on the rise worldwide, the nonprofit Critical Path Institute has won an $11.8 million grant from the Bill & Melinda…

The Netherlands-based organs-on-chips maker Mimetas and Belgium-based biotech Galapagos are capitalizing on the potential of this technology with a new…

Dutch InteRNA Technologies is collaborating with the Neuroallianz Consortium, an academic industry partnership with Belgium-based UCB and the Rheinische…

After launching a subsidiary that will focus on vaccines in December, Astellas Pharma is showing that it's serious about becoming a player in the vaccines…

Cancer Research UK has struck a deal with AstraZeneca to repurpose an experimental therapy originally developed by the drug giant for asthma and study its…